Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | FHTX | PRME | ||
| Company | Revance Therapeutics | Foghorn Therapeutics Inc | Prime Medicine Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.18 | 8.02 | 3.37 | ||
| High | 4.18 | 8.05 | 3.38 | ||
| Low | 3.98 | 7.36 | 3.14 | ||
| Last | 3.99 | 7.71 | 3.18 | ||
| Change | -0.18 | -0.30 | -0.16 | ||
| % Change | -4.32% | -3.75% | -4.93% | ||
| Volume | 1,391,300 | 127,400 | 2,071,100 | ||
| 20-Day Average Volume | 2,808,125 | 135,670 | 1,047,890 | ||
| Previous Close | 4.17 | 8.01 | 3.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.06 | 8.36 | 4.01 | ||
| 20-Day Raw Stochastic | 23.08% | 22.27% | 2.24% | ||
| 20-Day Relative Strength | 36.99% | 45.11% | 38.12% | ||
| Weighted Alpha | -57.68 | -3.28 | -65.97 | ||
| Today's Opinion | 8% Sell | 48% Buy | 88% Sell | ||
| Previous Opinion | 8% Sell | 56% Buy | 88% Sell | ||
| Last Month's Opinion | 40% Buy | 56% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +15.65% since 11/11/24 | -16.92% since 11/11/24 | -27.56% since 11/11/24 | ||
| Low | 3.42 on 11/12/24 | 7.33 on 11/15/24 | 3.14 on 11/18/24 | ||
| High | 4.36 on 11/14/24 | 9.33 on 11/13/24 | 4.49 on 11/13/24 | ||
| 1-Month | |||||
| %Chg | -24.57% since 10/18/24 | +0.52% since 10/18/24 | -27.40% since 10/18/24 | ||
| Low | 3.36 on 11/11/24 | 7.14 on 10/22/24 | 3.14 on 11/18/24 | ||
| High | 6.09 on 10/28/24 | 9.70 on 11/11/24 | 4.71 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | -39.73% since 08/16/24 | +23.16% since 08/16/24 | -25.00% since 08/16/24 | ||
| Low | 3.36 on 11/11/24 | 6.65 on 08/19/24 | 3.14 on 11/18/24 | ||
| High | 6.65 on 08/19/24 | 10.25 on 09/20/24 | 5.02 on 09/30/24 | ||
| 6-Month | |||||
| %Chg | +32.12% since 05/17/24 | +39.93% since 05/17/24 | -55.08% since 05/17/24 | ||
| Low | 2.30 on 06/26/24 | 4.77 on 07/10/24 | 3.14 on 11/18/24 | ||
| High | 6.65 on 08/19/24 | 10.25 on 09/20/24 | 8.27 on 05/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 418,559 | 428,622 | 417,092 | ||
| Shares Outstanding, K | 104,902 | 55,593 | 131,161 | ||
| Annual Sales | 234,040,000 | 34,160,000 | 0 | ||
| Annual Net Income | -323,990,000 | -98,430,000 | -198,130,000 | ||
| Last Quarter Sales | 59,880,000 | 7,810,000 | 210,000 | ||
| Last Quarter Net Income | -38,120,000 | -19,120,000 | -52,520,000 | ||
| 60-Month Beta | 0.95 | 3.14 | 2.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/07/24 | -0.31 on 11/04/24 | -0.44 on 11/12/24 | ||
| Latest Earnings Date | 11/13/24 | 11/07/24 | 11/15/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 09/10/19 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||